Harrow Health secures $125M financing package (notes, equity, loan) to fund acquisition

HARROW, INC.

Common stock offering: 2,376,426 shares at $10.52 for gross proceeds of $25M, closed Dec 16.
Senior notes offering: $35M principal of 11.875% notes due 2027, priced Dec 16, closing expected Dec 20.
B. Riley affiliate committed $65M secured loan at 10.875% fixed interest rate.
Management and directors purchased $950,000 of the senior notes.
Proceeds, along with sale of non-ophthalmology assets, to fund recently announced acquisition and general purposes.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

HARROW, INC. entered into Common Stock Underwriting Agreement with B. Riley Securities, Inc. valued at gross proceeds of $25,000,002 (effective 2022-12-13).

Action: entry
Agreement: underwriting
Counterparty: B. Riley Securities, Inc.
Value: gross proceeds of $25,000,002
Effective: 2022-12-13

Exact text from the filing

On December 13, 2022, Harrow Health, Inc. (the “Company”) entered into an underwriting agreement (the “ Common Stock Underwriting Agreement ”) with B. Riley Securities, Inc. (the “ Common Stock Underwriter ”) related to a registered direct offering of shares of the Company’s common stock

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

HARROW, INC. entered into Notes Underwriting Agreement with B. Riley Securities, Inc., as representative of the several underwriters named therein valued at $35,000,000 aggregate principal amount of 11.875% Senior Notes due 2027 (effective 2022-12-15).

Action: entry
Agreement: notes offering
Counterparty: B. Riley Securities, Inc., as representative of the several underwriters named therein
Value: $35,000,000 aggregate principal amount of 11.875% Senior Notes due 2027
Effective: 2022-12-15

Exact text from the filing

On December 15, 2022, the Company entered into an underwriting agreement (the “ Notes Underwriting Agreement ”) with B. Riley Securities, Inc., as representative of the several underwriters named therein (the “ Notes Underwriters ”), pursuant to which the Company agreed to sell to the Notes Underwriters $35,000,000 aggregate principal amount of 11.875% Senior Notes due 2027

View on SEC.gov

622 material agreements filed in the last 30 days. Browse all material agreements →

HARROW, INC. filing history →

Source: SEC EDGAR

accession 0001493152-22-035767

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.